Pathogenesis of Helicobacter pylori infection
1University of Maryland School of Medicine, Department of Microbiology and Immunology, Baltimore, Maryland 21201, USA.
Abstract:
Helicobacter pylori, a gram-negative, microaerophilic, motile, spiral-shaped bacterium, has been established as the etiologic agent of gastritis and peptic ulcers and is a major risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (MALT). The ability of H. pylori to cause this spectrum of diseases depends on host, bacterial, and environmental factors. Bacterial factors critical for H. pylori colonization of the gastric mucosa include urease, flagella, adhesins, and delta-glutamyltranspeptidase. Lipopolysaccharide, urease, and vacuolating cytotoxin are among the factors that allow H. pylori to persist for decades and invoke an intense inflammatory response, leading to damaged host cells. Genes in the cag pathogenicity island also contribute to the inflammatory response by initiating a signal transduction cascade, resulting in interleukin-8 production. Proinflammatory cytokines and a Th-1 cytokine response further exacerbates the inflammation. Products of the enzymes nitric oxide synthase (iNOS) and cyclooxygenase may perturb the balance between gastric epithelial cell apoptosis (ulcer formation) and proliferation (cancer). The host Th-1 response and antibodies directed against H. pylori do not eliminate the organism, which presents challenges to vaccine development. Vaccines that include urease have shown some promise, but improved adjuvants and animal models should hasten progress in vaccine research. H. pylori is the most genetically diverse organism known, and the panmictic population structure may contribute to the varying ranges of disease severity produced by different strains. The complete genome sequence of two strains of H. pylori has propelled this field forward, and numerous groups are now using genomic, proteomic, and mutagenetic approaches to identify new virulence genes. Discovered only in 1982, H. pylori is now among the most intensely investigated organisms. This review summarizes recent progress in this rapidly moving field.
Insights
Helicobacter pylori causes gastritis, ulcers, and gastric cancers by employing virulence factors like urease and cytotoxins. Research is advancing vaccine development and understanding its genetic diversity to combat these diseases.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Helicobacter pylori is a bacterium linked to gastritis, peptic ulcers, and gastric cancers.
- Its pathogenicity involves bacterial factors (urease, cytotoxins) and host immune responses.
- Genetic diversity of H. pylori influences disease severity.
Purpose of the Study:
- To review recent advancements in understanding Helicobacter pylori pathogenesis.
- To highlight challenges and progress in H. pylori vaccine development.
- To explore the impact of bacterial genetics on disease outcomes.
Main Methods:
- Review of current literature on H. pylori virulence factors and host interactions.
- Analysis of genomic, proteomic, and mutagenetic studies.
- Evaluation of H. pylori vaccine research progress.
Main Results:
- Key bacterial factors like urease, flagella, adhesins, and cytotoxins contribute to colonization and inflammation.
- Host inflammatory responses, including Th-1 cytokines, exacerbate tissue damage.
- H. pylori's genetic diversity and panmictic structure correlate with varying disease severities.
- Vaccine development faces challenges due to host immune responses but shows promise with urease-based vaccines.
Conclusions:
- Understanding H. pylori virulence factors and host responses is crucial for disease management.
- Continued research using genomic and proteomic approaches will identify new therapeutic targets.
- Advancements in vaccine adjuvants and animal models are essential for effective H. pylori vaccines.
Related Concept Videos
01:26Gastritis II: Pathophysiology
01:24Peptic Ulcer Disease II: Pathophysiology
01:28Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:27Peptic Ulcer
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...